Sarepta Therapeutics (SRPT) Change in Intangibles (2010 - 2026)
Sarepta Therapeutics (SRPT) recorded quarterly Change in Intangibles of $1.0 million in Q1 2026, up 112.92% quarter-over-quarter from -$7.7 million in Q4 2025, and down 55.32% on a YoY basis from $2.2 million in Q1 2025.
Sarepta Therapeutics (SRPT) Change in Intangibles (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Change in Intangibles history runs 17 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Change in Intangibles fell 55.32% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at -$1.2 million (up 84.05% YoY), while the FY2023 annual figure was $102.0 million, up 7047.86% from the prior year.
- Change in Intangibles was $1.0 million for Q1 2026 at Sarepta Therapeutics, up from -$7.7 million in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $101.9 million in Q3 2023 to a low of -$10.0 million in Q4 2024.
- Historically, Change in Intangibles has averaged $9.5 million across 5 years, with a median of $1.0 million in 2026.
- The sharpest annual moves came in 2024 and 2025: Change in Intangibles surged 10538.3% in 2024, then slumped 77.62% in 2025.
- A 5-year view of Change in Intangibles shows it stood at $1.4 million in 2022, then surged by 7038.12% to $101.9 million in 2023, then tumbled by 109.82% to -$10.0 million in 2024, then rose by 22.62% to -$7.7 million in 2025, then soared by 112.92% to $1.0 million in 2026.
- The last three Change in Intangibles figures came in at $1.0 million (Q1 2026), -$7.7 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | -7.74 Mn |
| Dec 31, 2025 | -7.74 Mn |
| Sep 30, 2025 | 5.31 Mn |
| Sep 30, 2025 | 5.31 Mn |
| Jun 30, 2025 | 188,000.00 |
| Jun 30, 2025 | 188,000.00 |
| Mar 31, 2025 | 2.24 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | -10.00 Mn |
| Dec 31, 2024 | -10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Sep 30, 2023 | 101.86 Mn |
| Sep 30, 2023 | 101.86 Mn |
| Jun 30, 2023 | 45,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 94,000.00 |
| Mar 31, 2023 | 94,000.00 |